Abstract: The present disclosure relates to lipid nanoparticles and methods of delivering active agents to target organs, tissues, or cells by utilizing the lipid nanoparticles.
Type:
Grant
Filed:
October 11, 2024
Date of Patent:
September 30, 2025
Assignee:
CodeBridgeBio Inc.
Inventors:
Oscar R. Miranda, Haitao Zhao, Xiaofeng Sun